Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2013; 19(39): 6618-6624
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6618
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6618
Control group | Anisodamine group | P value | |
(n = 97) | (n = 100) | ||
Age (yr) | 59.1 ± 10.9 | 58.0 ± 12.4 | 0.564 |
Sex | 0.422 | ||
Male | 42 (43.3) | 49 (49.0) | |
Female | 55 (56.7) | 51 (51.0) | |
Main presentations | |||
Biliary colic | 40 (41.2) | 44 (44.0) | 0.695 |
Cholangitis | 25 (25.8) | 27 (27.0) | 0.845 |
Jaundice | 20 (20.6) | 19 (19.0) | 0.776 |
Acute pancreatitis | 12 (12.4) | 10 (10.0) | 0.597 |
Median time interval from symptom onset to hospital admission | 0.606 | ||
< 24 h | 84 (86.6) | 89 (89.0) | |
≥ 24 h and ≤ 48 h | 13 (13.4) | 11 (11.0) | |
Imaging methods for diagnosis | 0.918 | ||
Conventional CT | 82 (84.5) | 84 (84.0) | |
MRCP | 15 (15.5) | 16 (16.0) | |
Median diameter of CBD stone | 0.54 ± 0.24 | 0.55 ± 0.24 | 0.837 |
Minimum, mm | 0.3 | 0.3 | |
Maximum, mm | 1.0 | 1.0 | |
Diameter of CBD stone | 0.959 | ||
< 5 mm | 44 (45.4) | 45 (45.0) | |
≥ 5 mm and ≤ 10 mm | 53 (54.6) | 55 (55.0) | . |
Median diameter of CBD | 12.6 ± 4.3 | 12.9 ± 3.8 | 0.683 |
Minimum, mm | 8.0 | 8.3 | |
Maximum, mm | 23.0 | 25.0 | |
History of cholecystectomy | 0.856 | ||
Yes | 27 (27.8) | 29 (29.0) | |
No | 70 (72.2) | 71 (71.0) |
Diameter of CBD stone | Control group | Anisodamine group | P value |
(n = 97) | (n = 100) | (intergroup) | |
< 5 mm | 31.8% (15/44) | 71.1% (31/45) | 0.001 |
≥ 5 mm and ≤ 10 mm | 15.1% (7/53) | 27.3% (16/55) | 0.044 |
Total | 22.7% (22/97) | 47.0% (47/100) | 0.000 |
Within-group P | 0.014 | 0.000 | |
Week 1 | 5.2% (5/97) | 17.0% (17/100) | 0.008 |
Week 2 | 5.4% (5/92) | 28.9% (24/83) | 0.000 |
Week 3 | 6.9% (6/87) | 5.1% (3/59)ac | 0.740 |
Week 4 | 7.4% (6/81) | 5.4% (3/56)ac | 0.737 |
Total | 22.7% (22/97) | 47.0% (47/100) | 0.000 |
Within-group P | 0.907 | 0 |
Parameters | Univariate analyses | Multivariate analyses | ||||
OR | 95%CI | P value | OR | 95%CI | P value | |
Age | 1.141 | 0.735-1.724 | 0.534 | |||
Sex | 0.980 | 0.545-1.763 | 0.947 | |||
Main presentation | 1.001 | 0.754-1.328 | 0.994 | |||
Diagnosis by imaging method | 0.976 | 0.438-2.177 | 0.954 | |||
Diameter of CBD stone | 2.847 | 1.819-4.458 | 0.000 | 3.095 | 1.927-4.970 | 0.000 |
Median diameter of CBD | 1.331 | 0.726-2.041 | 0.342 | |||
History of cholecystectomy | 1.070 | 0.557-2.054 | 0.839 | |||
Anisodamine treatment | 3.023 | 1.632-5.600 | 0.000 | 3.534 | 1.810-6.902 | 0.000 |
Median time interval from onset to hospital admission | 0.596 | 0.252-1.412 | 0.240 |
- Citation: Gao J, Ding XM, Ke S, Zhou YM, Qian XJ, Ma RL, Ning CM, Xin ZH, Sun WB. Anisodamine accelerates spontaneous passage of single symptomatic bile duct stones ≤ 10 mm. World J Gastroenterol 2013; 19(39): 6618-6624
- URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6618